PDB 6o3i

×

Network disruptions

We have been experiencing disruptions on our local network which has affected the stability of these web pages. We have been working with IT support team to get this fixed as a matter of urgency and apologise for any inconvenience.

PDB Links
Overview

PDB Information

PDB	6O3I
Method	X-RAY DIFFRACTION
Host Organism	Escherichia coli
Gene Source	Homo sapiens
Primary Citation	Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1. Kumar, S., Waldo, J.P., Jaipuri, F.A., Marcinowicz, A., Van Allen, C., Adams, J., Kesharwani, T., Zhang, X., Metz, R., Oh, A.J., Harris, S.F., Mautino, M.R. J.Med.Chem.
Header	Oxidoreductase/Inhibitor
Released	2019-02-26
Resolution	2.690
CATH Insert Date	04 Aug, 2019

PDB Images (3)

Image of CATH 6o3i

6o3i

PDB 6o3i

Image of CATH 6o3iA

6o3iA

PDB Chain 6o3iA

Image of CATH 6o3iB

6o3iB

PDB Chain 6o3iB

PDB Prints

PDB Chains (2)

Chain ID	Date inserted into CATH	CATH Status
A	04 Aug, 2019	New
B	04 Aug, 2019	New

CATH Domains (0)

Domain ID	Date inserted into CATH	Superfamily	CATH Status

UniProtKB Entries (0)

Accession	Gene ID	Taxon	Description